Sept Conference

• The CEO of Helus Pharma will participate in a live webcast on September 14 during the H.C. Wainwright conference in New York. • The presentation begins at 9 a.m. EDT and will be available for replay on the company's Events & Presentations page. • Investors and partners can gain direct insight into the company's current status and its various programs, including HLP003 and HLP004.

• Helus Pharma CEO Michael Halstead is scheduled to participate in a fireside chat during a conference on September 11. • The event will be webcast at 8 a.m. EDT, with a recording later made available on the company's investor relations website. • The presentation comes amid ongoing development of the company's NSA programs, including HLP003 and HLP004.

• France, serving as the President of the Security Council for September, announced a work programme focused on addressing critical issues in Haiti, Iran, and Sudan. • The agenda was detailed by the French representative during a press conference held at the UN Headquarters. • This scheduling is significant as it coincides with the upcoming gathering of world leaders for the General Assembly.